A single graph can reveal a lot about how Tenacibaculum maritimum infection progresses in Atlantic salmon—and why timing matters when evaluating potential solutions.

This experimental challenge shows mortality remaining relatively low early on before accelerating dramatically later in the study, reaching approximately 78% cumulative mortality by Day 32.

But the real question isn’t simply how many fish survive. It’s whether an intervention can change the curve.

Explore what this mortality curve tells us about disease progression, challenge models and evaluating vaccines, functional feeds and other strategies against T. maritimum.

When developing vaccines, functional feeds, therapeutics, or selective breeding programs, the challenge model you choose can significantly influence your results. In this article, we explore why different Infectious Pancreatic Necrosis Virus (IPNV) isolates produce different disease outcomes—and why testing against the right strain is essential for generating meaningful efficacy data. Learn how Onda's unique access to Chilean, Scottish, and Norwegian IPNV isolates helps clients develop products with greater confidence for their target markets.